| All Subjects (n = 184) | Telmisartan40/S-Amlodipine2.5 (n = 96) | Telmisartan80 (n = 88) | P-value |
---|---|---|---|---|
Male (n, %) | 105 (57.1) | 59 (61.5) | 46 (52.3) | 0.209a) |
Age, mean (year) | 63.1 ± 11.7 | 63.5 ± 12.5 | 62.7 ± 10.9 | 0.650b) |
Height (cm) | 162.3 ± 8.6 | 163.0 ± 8.2 | 161.6 ± 9.0 | 0.270a) |
Body weight (kg) | 70.0 ± 13.8 | 69.6 ± 11.1 | 70.5 ± 16.3 | 0.650a) |
HTN (n, %) | 184 (100.0) | 96 (100.0) | 88 (100.0) | Â |
Duration of HTN, mean (year) | 11.6 ± 9.1 | 12.0 ± 9.5 | 11.2 ± 8.6 | 0.580a) |
DM (n, %) | 65 (35.3) | 33 (34.4) | 32 (36.4) | 0.778a) |
Duration of DM (year) | 8.0 ± 9.2 | 7.3 ± 7.4 | 8.8 ± 10.8 | 0.532b) |
CKD (n, %) | 34 (18.5) | 18 (18.8) | 16 (18.2) | 0.921a) |
Office SBP (mmHg) | 153.1 ± 15.5 | 154.8 ± 16.0 | 151.2 ± 14.9 | 0.111a) |
Office DBP (mmHg) | 89.2 ± 11.9 | 88.9 ± 12.5 | 89.6 ± 11.4 | 0.677a) |
Heart rate (bpm) | 73.2 ± 12.6 | 72.6 ± 13.3 | 73.9 ± 11.7 | 0.486a) |
Body temperature (°C) | 36.5 ± 0.2 | 36.5 ± 0.2 | 36.5 ± 0.2 | 0.920a) |